InvestWiser

Optomed PLC

OPTOMEDNasdaq HelsinkiHealthcareMarket value 36 m EUR
1.70EUR −4.4%
last day · Price as of 18 November 2026

The answer first

Does Optomed beat the market?

No, Optomed has not beaten the market over the last year.

Optomed−56.7%Helsinki (OMXHGI)+17.3%
  • The ranking · Quality, value and trend combined

    Better than 48% of Nordic stocks

    • Quality70
    • Value31
    • Trend52

    No. 62 of 195 in healthcare

Max for seven days

Follow Optomed with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Optomed

From today, at a price of 1.70 EUR. Write why you follow Optomed, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Optomed

Your first answer is free, no account needed.

Do you own Optomed, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Optomed and a few more. Free, no card.

Past year against the exchange and Super Stock
Optomed−56.7%Helsinki (OMXHGI)+17.3%Super Stock+45.9%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Optomed has fallen 56.7% over the past year, including dividends.
  • Overall, Optomed ranks better than 48% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 85.6%. The price is 90.7% below its peak now.

What do analysts think of Optomed?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

48

Quality, value and trend together. Better than 48% of Nordic stocks.

No. 62 of 195 in healthcare

Quality70
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 84 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.15
  • Asset turnoverSales divided by everything the company owns0.57
  • Return on equityProfit divided by equity−15.4%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value31
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 75 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equity1.6
  • P/SPrice divided by sales2.1
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend52
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 68 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+5.7%
  • 6 months+15.2%
  • 9 months−39.7%
  • 12 months−56.7%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+25.0%
3 years, per year
−13.5%
5 years, per year
−29.5%
Year to date
−54.9%
Largest fall, 3 years
−85.6%
From a peak to the bottom
From the peak now
−90.7%
How far the price is from the peak
Volatility, 1 year
63.3%
How much the price swings over a year
Beta, 1 year
0.13
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Optomed

One fund we follow owns Optomed. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About Optomed

Optomed PLC is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR. It has around 100 employees.

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, Optomed Polaris, and Optomed Lumo brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands.

See the full analysis of Optomed.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Helsinki

Explore the stock market